About EMQN About EMQN

The European Molecular Genetics Quality Network (EMQN) is a provider of External Quality Assessment (EQA) services which are essential for any laboratory seeking to maintain and provide a quality service. The organization was established in 1998 after a successful pilot trial of a Huntington disease EQA scheme the previous year. From January 1999 to March 2002, the network was supported by a grant from the European Commission under the Standards Measurement and Testing Programme (contract number SMT4-CT98-7515). Since April 2002, EMQN activities have been supported by subscriptions from EQA scheme participants and currently EMQN offers molecular genetics, molecular pathology, and technique specific EQA schemes for molecular testing.

The EMQN is based at the Genetic Medicine Service, St Mary's Hospital, Manchester, The United Kingdom. Our Host organisation is Central Manchester University Hospitals NHS Foundation Trust (CMFT).

  • To help to raise and maintain the standards of diagnostic clinical molecular genetic testing.
  • To undertake and promote educational activities.
  • To be a leading authority in quality assurance .
  • To design and provide the best possible materials and data management.
  • To design and provide quality reports that are timely and valid.
  • To provide professional support and consultation.
  • To develop new EQA schemes as required.
  • To participate in peer review.
  • To strive for continual improvement of our quality systems.
Organisational Structure

The EMQN Office is located within the Department of Genetic Medicine, St Mary's Hospital, Manchester, UK. St Mary's Hospital is part of a much larger group of hospital collectively known as Central Manchester University Hospitals NHS Foundation Trust. You can find out more about the EMQN Office here.


The network is organised in a structure with three levels:

  1. A Management Board
  2. EQA Scheme Organisers and Assessors
  3. Registered Members

The management group is responsible for developing the network, commissioning new schemes and best practice meetings, appointing new scheme organisers, advising scheme organisers of the scientific content, and providing EQA materials and administration. The management board is ultimately responsible for the overall organisation and running of the network and comprises seven senior molecular geneticists from EU countries supported by an office team based in Manchester, UK.

Quality Policy

The EMQN provides a comprehensive range of quality assurance programs for molecular genetics to laboratories and industry worldwide. It is committed to helping ensure diagnostic molecular genetic laboratory test results are accurate, reliable and comparable wherever they are produced. The EMQN will provide a high quality and timely service which takes into account the needs and requirements of its members.

  •  Download a copy of our Quality Policy here

EMQN is a UKAS accredited provider of EQA services.  All EQA schemes are covered under its scope of accreditation unless explicitly stated otherwise. 

 UKAS Accreditation


Site by Certus Technology

EMQN is a UKAS accredited provider of EQA services

© EMQN 2017

 UKAS Proficiency Testing Symbol